Sentence examples for pharmaceutical presentation from inspiring English sources

However, the fact that only one pharmaceutical presentation is available for pediatric and adult patients could generate a waste of resources.

Hospital list prices for the immunoglobulins in the same pharmaceutical presentation differed between 219.40 and 246.18 Euro per unit depending on the purchased brand.

The EDL includes clear specifications for the rational use of each drug (patient age, dosage, administration route, treatment length, drug pharmaceutical presentation, drug time frequency, drug drug interactions, and contraindications).

In our country, until 2000 rocuronium was only provided as an ampoule containing 50 mL/5 mL, and since last year the pharmaceutical presentation was modified to a vial containing a similar concentration but allowing multiple sampling.

Whereas vecuronium is available in two pharmaceutical presentations, a single-sampling ampoule and a vial allowing multiple sampling.

Emollient gels are alternative pharmaceutical presentations for atopic eczema sufferers and usually contain high concentrations of oily ingredients in semisolid aqueous systems.

We report the results of an assessor-blinded, bilateral, concurrent comparison of two emollient pharmaceutical presentations, ie, Doublebase gel (DB) and Aqueous cream BP (AC), applied by 20 participants three times daily for 7 consecutive days.

The changes in pharmaceutical presentations may mean an extra difficulty since they often suffer from visual deficiencies, and even cognitive ones, which can increase the risk of mistakes [ 9].

In relation to the pharmaceutical presentations of vecuronium and rocuronium, most of the anesthesiologists preferred rocuronium in a vial for multiple sampling and considered that vecuronium could be presented either in a vial for single or multiple sampling (Table 2).

Of particular relevance is a systematic review by De Craen et al. [ 8], published in British Medical Journal, including 6 clinical trials that evaluated the effect of the color of pharmaceutical drug presentations on various factors, for example relating the drug color to a stimulating or depressive effect on the nervous system, or to the location of the effect.

Recently, I attended a seminar sponsored by the Association for Women in Science where a patent examiner from the United States Patent and Trademark Office (USPTO), a patent attorney from an area law firm, and a consultant at pharmaceutical company gave presentations on their respective career fields.